L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma

NCT07228442 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Cutaneous Squamous Cell Carcinoma

Interventions

DRUG: L19IL2/L19TNF

Sponsor

Philogen S.p.A.